-
1
-
-
0037432305
-
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
-
Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
-
(2003)
Circulation
, vol.107
, pp. 1303-1307
-
-
Solomon, D.H.1
Karlson, E.W.2
Rimm, E.B.3
Cannuscio, C.C.4
Mandl, L.A.5
Manson, J.E.6
-
2
-
-
57149096904
-
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies
-
Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690–7.
-
(2008)
Arthritis Rheum
, vol.59
, pp. 1690-1697
-
-
Avina-Zubieta, J.A.1
Choi, H.K.2
Sadatsafavi, M.3
Etminan, M.4
Esdaile, J.M.5
Lacaille, D.6
-
3
-
-
84982791282
-
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
-
Meissner Y, Zink A, Kekow J, Rockwitz K, Liebhaber A, Zinke S, et al. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Res Ther 2016;18:183.
-
(2016)
Arthritis Res Ther
, vol.18
, pp. 183
-
-
Meissner, Y.1
Zink, A.2
Kekow, J.3
Rockwitz, K.4
Liebhaber, A.5
Zinke, S.6
-
4
-
-
77956503955
-
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
-
Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010;69:1920–5.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1920-1925
-
-
Solomon, D.H.1
Kremer, J.2
Curtis, J.R.3
Hochberg, M.C.4
Reed, G.5
Tsao, P.6
-
5
-
-
84956767541
-
2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
-
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016;68:1–26.
-
(2016)
Arthritis Rheumatol
, vol.68
, pp. 1-26
-
-
Singh, J.A.1
Saag, K.G.2
Bridges, S.L.3
Akl, E.A.4
Bannuru, R.R.5
Sullivan, M.C.6
-
6
-
-
84922387653
-
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
-
Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015;74:480–9.
-
(2015)
Ann Rheum Dis
, vol.74
, pp. 480-489
-
-
Roubille, C.1
Richer, V.2
Starnino, T.3
McCourt, C.4
McFarlane, A.5
Fleming, P.6
-
7
-
-
79957461056
-
Systematic review and meta-analysis: anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis
-
Barnabe C, Martin BJ, Ghali WA. Systematic review and meta-analysis: anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011;63:522–9.
-
(2011)
Arthritis Care Res (Hoboken)
, vol.63
, pp. 522-529
-
-
Barnabe, C.1
Martin, B.J.2
Ghali, W.A.3
-
8
-
-
79952351318
-
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
-
Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 2011;70:576–82.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 576-582
-
-
Greenberg, J.D.1
Kremer, J.M.2
Curtis, J.R.3
Hochberg, M.C.4
Reed, G.5
Tsao, P.6
-
9
-
-
84880612195
-
Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs
-
Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, et al. Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs. Am J Med 2013;126:730.e9–17.
-
(2013)
Am J Med
, vol.126
, pp. 730.e9-17
-
-
Solomon, D.H.1
Curtis, J.R.2
Saag, K.G.3
Lii, J.4
Chen, L.5
Harrold, L.R.6
-
10
-
-
84923227881
-
Tumor necrosis factor-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis: a nested case-control study
-
Desai RJ, Rao JK, Hansen RA, Fang G, Maciejewski M, Farley J. Tumor necrosis factor-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis: a nested case-control study. J Rheumatol 2014;41:2129–36.
-
(2014)
J Rheumatol
, vol.41
, pp. 2129-2136
-
-
Desai, R.J.1
Rao, J.K.2
Hansen, R.A.3
Fang, G.4
Maciejewski, M.5
Farley, J.6
-
11
-
-
34848898513
-
on behalf of the British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
-
Dixon WG, Watson KD, Lunt M, Hyrich KL, British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, et al, on behalf of the British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56:2905–12.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2905-2912
-
-
Dixon, W.G.1
Watson, K.D.2
Lunt, M.3
Hyrich, K.L.4
Silman, A.J.5
-
12
-
-
73449118587
-
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
-
Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, et al. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis 2010;69:88–96.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 88-96
-
-
Jones, G.1
Sebba, A.2
Gu, J.3
Lowenstein, M.B.4
Calvo, A.5
Gomez-Reino, J.J.6
-
13
-
-
2642558925
-
Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial
-
Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2004;50:1761–9.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 1761-1769
-
-
Nishimoto, N.1
Yoshizaki, K.2
Miyasaka, N.3
Yamamoto, K.4
Kawai, S.5
Takeuchi, T.6
-
14
-
-
40749114497
-
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
-
Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008;371:987–97.
-
(2008)
Lancet
, vol.371
, pp. 987-997
-
-
Smolen, J.S.1
Beaulieu, A.2
Rubbert-Roth, A.3
Ramos-Remus, C.4
Rovensky, J.5
Alecock, E.6
-
15
-
-
85021858218
-
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
-
Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, et al. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 2016;75:1806–12.
-
(2016)
Ann Rheum Dis
, vol.75
, pp. 1806-1812
-
-
Gabay, C.1
McInnes, I.B.2
Kavanaugh, A.3
Tuckwell, K.4
Klearman, M.5
Pulley, J.6
-
16
-
-
84877275257
-
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
-
Gabay C, Emery P, van Vollenhoven R, Dikranian A, Alten R, Pavelka K, et al. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. Lancet 2013;381:1541–50.
-
(2013)
Lancet
, vol.381
, pp. 1541-1550
-
-
Gabay, C.1
Emery, P.2
van Vollenhoven, R.3
Dikranian, A.4
Alten, R.5
Pavelka, K.6
-
17
-
-
84922780682
-
An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy
-
Rao VU, Pavlov A, Klearman M, Musselman D, Giles JT, Bathon JM, et al. An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol 2015;67:372–80.
-
(2015)
Arthritis Rheumatol
, vol.67
, pp. 372-380
-
-
Rao, V.U.1
Pavlov, A.2
Klearman, M.3
Musselman, D.4
Giles, J.T.5
Bathon, J.M.6
-
18
-
-
84879490766
-
US government claims databases
-
In, Strom B, Kimmel S, Hennessy S, editors., 5th ed, Philadelphia, Wiley-Blackwell, p
-
Hennessy S, Freeman C, Cunningham F. US government claims databases. In: Strom B, Kimmel S, Hennessy S, editors. Pharmacoepidemiology. 5th ed. Philadelphia: Wiley-Blackwell; 2012. p. 209–23.
-
(2012)
Pharmacoepidemiology
, pp. 209-223
-
-
Hennessy, S.1
Freeman, C.2
Cunningham, F.3
-
19
-
-
36549001139
-
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
-
Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424–9.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 1424-1429
-
-
Kappelman, M.D.1
Rifas-Shiman, S.L.2
Kleinman, K.3
Ollendorf, D.4
Bousvaros, A.5
Grand, R.J.6
-
20
-
-
84958852771
-
A US claims-based analysis of real-world lipid-lowering treatment patterns in patients with high cardiovascular disease risk or a previous coronary event
-
Quek RG, Fox KM, Wang L, Li L, Gandra SR, Wong ND. A US claims-based analysis of real-world lipid-lowering treatment patterns in patients with high cardiovascular disease risk or a previous coronary event. Am J Cardiol 2016;117:495–500.
-
(2016)
Am J Cardiol
, vol.117
, pp. 495-500
-
-
Quek, R.G.1
Fox, K.M.2
Wang, L.3
Li, L.4
Gandra, S.R.5
Wong, N.D.6
-
21
-
-
79951850197
-
Validation of rheumatoid arthritis diagnoses in health care utilization data
-
Kim SY, Servi A, Polinski JM, Mogun H, Weinblatt ME, Katz JN, et al. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 2011;13:R32.
-
(2011)
Arthritis Res Ther
, vol.13
, pp. R32
-
-
Kim, S.Y.1
Servi, A.2
Polinski, J.M.3
Mogun, H.4
Weinblatt, M.E.5
Katz, J.N.6
-
22
-
-
3142651905
-
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records
-
Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004;148:99–104.
-
(2004)
Am Heart J
, vol.148
, pp. 99-104
-
-
Kiyota, Y.1
Schneeweiss, S.2
Glynn, R.J.3
Cannuscio, C.C.4
Avorn, J.5
Solomon, D.H.6
-
23
-
-
84856025109
-
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
-
Andrade SE, Harrold LR, Tjia J, Cutrona SL, Saczynski JS, Dodd KS, et al. A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf 2012;21 Suppl 1:100–28.
-
(2012)
Pharmacoepidemiol Drug Saf
, vol.21 Suppl 1
, pp. 100-128
-
-
Andrade, S.E.1
Harrold, L.R.2
Tjia, J.3
Cutrona, S.L.4
Saczynski, J.S.5
Dodd, K.S.6
-
24
-
-
84922330102
-
Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with Medicare claims
-
Kumamaru H, Judd SE, Curtis JR, Ramachandran R, Hardy NC, Rhodes JD, et al. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with Medicare claims. Circ Cardiovasc Qual Outcomes 2014;7:611–9.
-
(2014)
Circ Cardiovasc Qual Outcomes
, vol.7
, pp. 611-619
-
-
Kumamaru, H.1
Judd, S.E.2
Curtis, J.R.3
Ramachandran, R.4
Hardy, N.C.5
Rhodes, J.D.6
-
25
-
-
51249122241
-
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study
-
Ting G, Schneeweiss S, Scranton R, Katz JN, Weinblatt ME, Young M, et al. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther 2008;10:R95.
-
(2008)
Arthritis Res Ther
, vol.10
, pp. R95
-
-
Ting, G.1
Schneeweiss, S.2
Scranton, R.3
Katz, J.N.4
Weinblatt, M.E.5
Young, M.6
-
26
-
-
79956217851
-
A combined comorbidity score predicted mortality in elderly patients better than existing scores
-
Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 2011;64:749–59.
-
(2011)
J Clin Epidemiol
, vol.64
, pp. 749-759
-
-
Gagne, J.J.1
Glynn, R.J.2
Avorn, J.3
Levin, R.4
Schneeweiss, S.5
-
27
-
-
84869868871
-
Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments
-
Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, et al. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol 2012;12:180.
-
(2012)
BMC Med Res Methodol
, vol.12
, pp. 180
-
-
Schneeweiss, S.1
Rassen, J.A.2
Glynn, R.J.3
Myers, J.4
Daniel, G.W.5
Singer, J.6
-
28
-
-
0030862072
-
Estimating causal effects from large data sets using propensity scores
-
Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757–63.
-
(1997)
Ann Intern Med
, vol.127
, pp. 757-763
-
-
Rubin, D.B.1
-
29
-
-
84860597391
-
One-to-many propensity score matching in cohort studies
-
Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf 2012;21 Suppl 2:69–80.
-
(2012)
Pharmacoepidemiol Drug Saf
, vol.21 Suppl 2
, pp. 69-80
-
-
Rassen, J.A.1
Shelat, A.A.2
Myers, J.3
Glynn, R.J.4
Rothman, K.J.5
Schneeweiss, S.6
-
30
-
-
77958600686
-
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
-
Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150–61.
-
(2011)
Pharm Stat
, vol.10
, pp. 150-161
-
-
Austin, P.C.1
-
31
-
-
84897968569
-
Metrics for covariate balance in cohort studies of causal effects
-
Franklin JM, Rassen JA, Ackermann D, Bartels DB, Schneeweiss S. Metrics for covariate balance in cohort studies of causal effects. Stat Med 2014;33:1685–99.
-
(2014)
Stat Med
, vol.33
, pp. 1685-1699
-
-
Franklin, J.M.1
Rassen, J.A.2
Ackermann, D.3
Bartels, D.B.4
Schneeweiss, S.5
-
32
-
-
0037207490
-
Matched-pair cohort methods in traffic crash research
-
Cummings P, McKnight B, Weiss NS. Matched-pair cohort methods in traffic crash research. Accid Anal Prev 2003;35:131–41.
-
(2003)
Accid Anal Prev
, vol.35
, pp. 131-141
-
-
Cummings, P.1
McKnight, B.2
Weiss, N.S.3
-
33
-
-
0019349374
-
Vasectomy and non-fatal myocardial infarction
-
Walker AM, Jick H, Hunter JR, Danford A, Watkins RN, Alhadeff L, et al. Vasectomy and non-fatal myocardial infarction. Lancet 1981;1:13–5.
-
(1981)
Lancet
, vol.1
, pp. 13-15
-
-
Walker, A.M.1
Jick, H.2
Hunter, J.R.3
Danford, A.4
Watkins, R.N.5
Alhadeff, L.6
-
34
-
-
84874985489
-
Researcher allegiance in psychotherapy outcome research: an overview of reviews
-
Munder T, Brutsch O, Leonhart R, Gerger H, Barth J. Researcher allegiance in psychotherapy outcome research: an overview of reviews. Clin Psychol Rev 2013;33:501–11.
-
(2013)
Clin Psychol Rev
, vol.33
, pp. 501-511
-
-
Munder, T.1
Brutsch, O.2
Leonhart, R.3
Gerger, H.4
Barth, J.5
-
35
-
-
84938152435
-
Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non–rheumatoid arthritis patients
-
Liao KP, Liu J, Lu B, Solomon DH, Kim SC. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non–rheumatoid arthritis patients. Arthritis Rheumatol 2015;67:2004–10.
-
(2015)
Arthritis Rheumatol
, vol.67
, pp. 2004-2010
-
-
Liao, K.P.1
Liu, J.2
Lu, B.3
Solomon, D.H.4
Kim, S.C.5
-
36
-
-
79951517914
-
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
-
Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011;70:482–7.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 482-487
-
-
Myasoedova, E.1
Crowson, C.S.2
Kremers, H.M.3
Roger, V.L.4
Fitz-Gibbon, P.D.5
Therneau, T.M.6
-
37
-
-
84883458926
-
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
-
Robertson J, Peters MJ, McInnes IB, Sattar N. Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 2013;9:513–23.
-
(2013)
Nat Rev Rheumatol
, vol.9
, pp. 513-523
-
-
Robertson, J.1
Peters, M.J.2
McInnes, I.B.3
Sattar, N.4
-
38
-
-
84954369755
-
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration
-
Navarro-Millán I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, et al. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis 2016;75:341–7.
-
(2016)
Ann Rheum Dis
, vol.75
, pp. 341-347
-
-
Navarro-Millán, I.1
Yang, S.2
DuVall, S.L.3
Chen, L.4
Baddley, J.5
Cannon, G.W.6
-
39
-
-
33745593028
-
Effects of anti-TNF-α treatment on lipid profile in patients with active rheumatoid arthritis
-
Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M. Effects of anti-TNF-α treatment on lipid profile in patients with active rheumatoid arthritis. Ann N Y Acad Sci 2006;1069:414–9.
-
(2006)
Ann N Y Acad Sci
, vol.1069
, pp. 414-419
-
-
Seriolo, B.1
Paolino, S.2
Sulli, A.3
Fasciolo, D.4
Cutolo, M.5
-
40
-
-
84956684746
-
Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis
-
Zhang J, Xie F, Yun H, Chen L, Muntner P, Levitan EB, et al. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Ann Rheum Dis 2016;75:1813–8.
-
(2016)
Ann Rheum Dis
, vol.75
, pp. 1813-1818
-
-
Zhang, J.1
Xie, F.2
Yun, H.3
Chen, L.4
Muntner, P.5
Levitan, E.B.6
-
41
-
-
0142157169
-
Evaluating medication effects outside of clinical trials: new-user designs
-
Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915–20.
-
(2003)
Am J Epidemiol
, vol.158
, pp. 915-920
-
-
Ray, W.A.1
-
42
-
-
84933676446
-
Active-comparator design and new-user design in observational studies
-
Yoshida K, Solomon DH, Kim SC. Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol 2015;11:437–41.
-
(2015)
Nat Rev Rheumatol
, vol.11
, pp. 437-441
-
-
Yoshida, K.1
Solomon, D.H.2
Kim, S.C.3
|